Early-phase and preclinical studies suggest that moxifloxacin-containing regimens could allow for effective 4-month treatment of uncomplicated, smear-positive pulmonary tuberculosis. We conducted ...

Tuberculosis regimens that are shorter and simpler than the current 6-month daily regimen are needed. We randomly assigned patients with newly diagnosed, smear-positive, drug-sensitive ...

Moxifloxacin (as HCl) 400mg/250mL; soln for IV infusion; latex- and preservative-free. Moxifloxacin inhibits topoisomerase II (DNA gyrase) and topoisomerase IV, which are required for bacterial ...

It alerts doctors and patients about drug effects that may be dangerous. Moxifloxacin oral tablet is available as a brand-name drug and a generic drug. Brand name: Avelox. Moxifloxacin comes as a ...

The activity, pharmacokinetics, pharmacodynamics, efficacy, safety, drug interactions, and dosage and administration of moxifloxacin are reviewed. Moxifloxacin is an oral 8-methoxyquinolone ...

WASHINGTON — Hopes for a new, moxifloxacin-containing tuberculosis (TB) treatment that might have shortened therapy from 6 to 4 months suffered a setback today with the results of REMoxTB study ...